Literature DB >> 19161429

Interleukin-35: odd one out or part of the family?

Lauren W Collison1, Dario A A Vignali.   

Abstract

Advances in cytokine biology have helped us understand the complex communication that takes place between antigen-presenting cells and cells of the adaptive immune system, such as T cells, which collectively mediate an appropriate immune response to a plethora of pathogens while maintaining tolerance to self-antigens. The interleukin-12 (IL-12) cytokine family remains one of the most important and includes IL-12, IL-23, IL-27, and the recently identified IL-35. All four are heterodimeric cytokines, composed of an alpha chain (p19, p28, or p35) and a beta chain (p40 or Ebi3), and signal through unique pairings of five receptor chains (IL-12Rbeta1, IL-12Rbeta2, IL-23R, gp130, and WSX-1). Despite the interrelationship between the cytokines themselves and their receptors, their source, activity, and kinetics of expression are quite different. Studies using genetically deficient mice have greatly enhanced our understanding of the biology of these cytokines. However, interpretation of these data has been complicated by the recent realization that p40(-/-), p35(-/-), and Ebi3(-/-) mice all lack more than one cytokine (IL-12/IL-23, IL-12/IL-35, and IL-27/IL-35, respectively). In this review, we compare and contrast the biology of this expanded IL-12 family and re-evaluate data derived from the analysis of these dual cytokine-deficient mice. We also discuss how the opposing characteristics of the IL-12 family siblings may help to promote a balanced immune response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19161429      PMCID: PMC2631363          DOI: 10.1111/j.1600-065X.2008.00704.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  129 in total

Review 1.  Regulation of interleukin-12 production in antigen-presenting cells.

Authors:  X Ma; G Trinchieri
Journal:  Adv Immunol       Date:  2001       Impact factor: 3.543

Review 2.  Control of intestinal inflammation by regulatory T cells.

Authors:  B Singh; S Read; C Asseman; V Malmström; C Mottet; L A Stephens; R Stepankova; H Tlaskalova; F Powrie
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

3.  Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma.

Authors:  U Grohmann; M L Belladonna; Carmine Vacca; R Bianchi; F Fallarino; C Orabona; M C Fioretti; P Puccetti
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

4.  T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells.

Authors:  A A Lighvani; D M Frucht; D Jankovic; H Yamane; J Aliberti; B D Hissong; B V Nguyen; M Gadina; A Sher; W E Paul; J J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

5.  Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets.

Authors:  H Hochrein; K Shortman; D Vremec; B Scott; P Hertzog; M O'Keeffe
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

6.  Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit.

Authors:  G L Costa; M R Sandora; A Nakajima; E V Nguyen; C Taylor-Edwards; A J Slavin; C H Contag; C G Fathman; J M Benson
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

7.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.

Authors:  B Oppmann; R Lesley; B Blom; J C Timans; Y Xu; B Hunte; F Vega; N Yu; J Wang; K Singh; F Zonin; E Vaisberg; T Churakova; M Liu; D Gorman; J Wagner; S Zurawski; Y Liu; J S Abrams; K W Moore; D Rennick; R de Waal-Malefyt; C Hannum; J F Bazan; R A Kastelein
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

Review 8.  IL-12/IL-13 axis in allergic asthma.

Authors:  M Wills-Karp
Journal:  J Allergy Clin Immunol       Date:  2001-01       Impact factor: 10.793

9.  WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection.

Authors:  H Yoshida; S Hamano; G Senaldi; T Covey; R Faggioni; S Mu; M Xia; A C Wakeham; H Nishina; J Potter; C J Saris; T W Mak
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

10.  IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together.

Authors:  Estelle Bettelli; Vijay K Kuchroo
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

View more
  99 in total

1.  Hepatitis B Virus Core Particles Containing a Conserved Region of the G Protein Combined with Interleukin-35 Protected Mice against Respiratory Syncytial Virus Infection without Vaccine-Enhanced Immunopathology.

Authors:  Jie Yang; Chen Ma; Yu Zhao; Anjing Fan; Xiufen Zou; Zishu Pan
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Phenotype and function of regulatory T cells in the genital tract.

Authors:  Janina Jiang; Kathleen A Kelly
Journal:  Curr Trends Immunol       Date:  2011

3.  IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis.

Authors:  Nasim Akhtar Ansari; Rajiv Kumar; Shalini Gautam; Susanne Nylén; Om Prakash Singh; Shyam Sundar; David Sacks
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

Review 4.  T-cell exhaustion: characteristics, causes and conversion.

Authors:  John S Yi; Maureen A Cox; Allan J Zajac
Journal:  Immunology       Date:  2010-02-23       Impact factor: 7.397

5.  Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.

Authors:  Z Cai; C K Wong; J Dong; M Chu; D Jiao; N W Kam; C W K Lam; L S Tam
Journal:  Clin Exp Immunol       Date:  2015-08       Impact factor: 4.330

Review 6.  Possible roles of IL-12-family cytokines in rheumatoid arthritis.

Authors:  Richard M Pope; Shiva Shahrara
Journal:  Nat Rev Rheumatol       Date:  2012-10-23       Impact factor: 20.543

Review 7.  Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases.

Authors:  Shi-Yang Guan; Rui-Xue Leng; Muhammad Imran Khan; Humera Qureshi; Xiang-Pei Li; Dong-Qing Ye; Hai-Feng Pan
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

8.  Autoimmunity: increasing suspects in the CD4+ T cell lineup.

Authors:  Matthew T Palmer; Casey T Weaver
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

9.  Inhibition of secretion of interleukin (IL)-12/IL-23 family cytokines by 4-trifluoromethyl-celecoxib is coupled to degradation via the endoplasmic reticulum stress protein HERP.

Authors:  Martin McLaughlin; Iraide Alloza; Hung Pham Quoc; Christopher J Scott; Yasuhiko Hirabayashi; Koen Vandenbroeck
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

10.  Interleukin-35 upregulates OPG and inhibits RANKL in mice with collagen-induced arthritis and fibroblast-like synoviocytes.

Authors:  Y Li; D Li; Y Li; S Wu; S Jiang; T Lin; L Xia; H Shen; J Lu
Journal:  Osteoporos Int       Date:  2015-11-16       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.